Skip to content

Clinical trials

Completed Phase 2/3 Coronavirus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Phase: Phase 2/3 Status: Completed Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202017
20214
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ModernaTX, Inc.4
BioNTech SE2
Dr. Ferrer BioPharma2
APR Applied Pharma Research s.a.1
Assistance Publique - Hôpitaux de Paris1
Butantan Institute1
Hamad Medical Corporation1
Instituto de Investigación Hospital Universitario La Paz1
NPO Petrovax1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections25
COVID-1923
Virus Diseases5
Respiratory Distress Syndrome2
Severe Acute Respiratory Syndrome2
Signs and Symptoms2
Acute Lung Injury1
Coronaviridae Infections1
Cytokine Release Syndrome1
Lung Diseases1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.